Results 231 to 240 of about 179,002 (365)

Underrecognised Functional Hyposplenism Associated With Chronic Graft-Versus-Host Disease: A Case Report. [PDF]

EJHaem
Uchino K, Nakagami Y, Enotomoto M, Shimizu N, Kondo K, Yamamoto T, Sugita Y, Seki H, Saigusa S, Iida Y, Shinohara S, Takasugi S, Horio T, Murakami S, Mizuno S, Ikegame K, Hanamura I, Takami A.   +17 more
europepmc   +1 more source

Esophageal abnormalities in chronic graft-versus-host disease in humans

, 1981
George B. McDonald, Keith M. Sullivan, Michael D. Schuffler, Howard M. Shulman, E. Donnall Thomas   +4 more
openalex   +1 more source

Chronic graft-versus-host disease, autoimmunity and microvascular pathology : an experimental approach to scleroderma [PDF]

, 1989
Gerard M.J. Bos
openalex   +1 more source

Watching the Barn Door Open—Timing CML Stem Cell Allografts

American Journal of Hematology, EarlyView.
Jeffrey H. Lipton
wiley   +1 more source

Discovery of Novel Pyrido[2,3‐b]Pyrazine Human Cytomegalovirus Polymerase Inhibitors with Broad Spectrum Antiherpetic Activity and Reduced hERG Inhibition

ChemMedChem, Volume 20, Issue 6, March 15, 2025.
We designed and synthesized a small library of novel non‐nucleoside, polymerase inhibitors of herpesviruses with a pyrido[2,3‐b]pyrazines core. Compound 27, a representative of the library, were identified with reduced hERG inhibition, and broad spectrum antiherpetic activity.
Bing Bai, Appan Srinivas Kandadai, Mostofa Hena, Alexandr Belovodskiy, John Shen, Michael Houghton, James A. Nieman   +6 more
wiley   +1 more source

Targeting the chemokines in acute graft-versus-host disease. [PDF]

Front Immunol
Xu Z, Wang H.
europepmc   +1 more source

Japan's Conditional/Time‐Limited Early Approval System in Regenerative Medicine: A Case Study of Rise and Falls of Autologous Skeletal Myoblast Sheets

Clinical Pharmacology &Therapeutics, Volume 117, Issue 5, Page 1171-1174, May 2025.
Japan's conditional/time‐limited early approval program, initiated in 2014, aimed to advance regenerative medicine by expediting market access. However, the withdrawal of autologous skeletal myoblast sheets (Heartsheet) due to ineffectiveness raises concerns about the balance between rapid approval and scientific integrity.
Hayase Hakariya, Akihiko Ozaki, Yudai Kaneda, Tetsuya Tanimoto   +3 more
wiley   +1 more source

Risk factors of ocular graft-versus-host disease after allogeneic haematopoietic stem cell transplantation in Denmark. [PDF]

Acta Ophthalmol
Jeppesen H.
europepmc   +1 more source

Model‐Based Prediction of Clinically Relevant Thrombocytopenia after Allogeneic Hematopoietic Stem Cell Transplantation

Clinical Pharmacology &Therapeutics, Volume 117, Issue 5, Page 1413-1426, May 2025.
Platelet reconstitution after allogeneic hematopoietic cell transplantation (allo‐HCT) is heterogeneous and influenced by various patient‐ and transplantation‐related factors, associated with poor prognoses for poor graft function (PGF) and isolated thrombocytopenia.
Katharina M. Götz, Amin T. Turki, Katharina Och, Dominik Selzer, Christian Brossette, Norbert Graf, Jochen Rauch, Stefan Theobald, Yvonne Braun, Kerstin Rohm, Gabriele Weiler, Simeon Rüdesheim, Matthias Schwab, Lisa Eisenberg, Nico Pfeifer, Stephan Kiefer, Ulf Schwarz, Claudia Riede, Sigrun Smola, Dietrich W. Beelen, Dominic Kaddu‐Mulindwa, Jürgen Rissland, Jörg Bittenbring, Thorsten Lehr   +23 more
wiley   +1 more source

Chronic graft-versus-host disease myelitis successfully treated with rituximab. [PDF]

Int J Hematol
Yokoyama E, Hasegawa Y, Wakaki K, Suzuki T, Kajikawa S, Kanaya M, Izumiyama K, Saito M, Morioka M, Nagai J, Ichiki T, Kikuchi R, Okada S, Ohigashi H, Goto H, Onozawa M, Hashimoto D, Mori A, Teshima T, Kondo T.   +19 more
europepmc   +1 more source